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Peripheral arterial disease (PAD) is a manifestation of ath-
erosclerosis in the peripheral arteries, resulting in reduced 
lower limb tissue perfusion.1 There is limited evidence on 
the prevalence of PAD; however, about 15% to 20% of the 
UK population aged 55 to 75 years have evidence of lower 
extremity PAD on objective testing.1,2 To put this into per-
spective, a general practice (GP) with 20 000 registered 
patients would expect to see 40 newly diagnosed patients 
with PAD each year.3 PAD poses a significant disease bur-
den carrying a poor prognosis once well established; partly 
owing to its association with cerebral and coronary artery 
disease, which is concomitant in 65% of PAD patients.4 The 
most common symptom is intermittent claudication (IC), 
which causes predictable and repeatable ischemic pain in 
the calf on exertion due to reduced tissue perfusion relieved 
by rest. However, many patients are asymptomatic with IC 
only present in approximately 4.5% of patients aged 55 to 
74 years.2 As the disease progresses a patient may then pres-
ent with ischemic pain at rest, tissue gangrene, ulceration, 
or necrosis collectively known as critical limb ischemia 
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Abstract
Background: Approximately 20% of the UK population aged 55 to 75 years have evidence of peripheral arterial disease 
(PAD). PAD affects quality of life and life expectancy if not appropriately diagnosed and managed. At risk patients require 
accurate diagnosis to ensure optimal treatment to slow disease progression and minimize adverse outcomes. Aim: To assess 
the accuracy of general practice (GP) registration of the diagnosis of peripheral arterial disease (PAD). Design and Setting: 
An observational analytic case-control study. As part of a National Institute for Health Research–funded (ISRCTN13301188) 
project assessing novel diagnostic methods set in GP practice. Methods: A total of 125 patients registered as having PAD 
and 125 age- and sex-matched controls were recruited from 15 general practices across North East England. The register 
was then assessed for accuracy of diagnosis. Duplex vascular ultrasound scanning (DUS) undertaken by vascular scientists 
was used as the gold standard reference for PAD. Results: The PAD register had a sensitivity of 86% (95% CI 77%-92%) and 
specificity of 74% (95% CI 67%-81%) when compared with DUS. The positive predictive value, however, was 69.6% (95% CI 
63%-75%) and negative predictive value 88.8% (95% CI 82%-92%). The overall diagnostic effectiveness of the PAD register 
was 79.2% (95% CI 73%-84%). Conclusion: This analysis indicates that while PAD is detected with reasonable sensitivity 
in primary care, many patients registered with a diagnosis of PAD lacked DUS-proven disease. Improved approaches to the 
objective diagnosis of PAD may improve diagnosis and management of PAD in primary care.
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(CLI). CLI has a 50% to 60% 5-year survival and is associ-
ated with minor and major amputations.5
The prevalence of PAD in the population depends on 
whether the diagnosis is made on clinical grounds only 
instead of using objective methods such as ankle brachial 
pressure index (ABPI). It also depends on the definition of 
PAD used and the population studied.6 The standard test 
recommended by NICE (National Institute for Health and 
Care Excellence) for confirmation of a diagnosis of PAD in 
GP is the ABPI. ABPI is noninvasive, inexpensive, and has 
reasonable inter- and intraobserver reliability,7 though it is 
not without a number of limitations in assessing PAD in 
primary care.8 It is a clinical imperative that “at-risk” 
patients are accurately diagnosed to ensure optimal, early 
treatment to reduce risk of disease progression, while mini-
mizing unnecessary treatment of patients without proven 
disease.
Assessment of PAD in primary care classically relies on 
a combination of clinical assessment, ABPI measurements, 
and clinical risk stratifying tools.6 Previous work has 
assessed these components individually in their clinical 
utility at assessing peripheral vascular disease in primary 
care.6 This study examines the GP’s assessment of periph-
eral arterial disease as a whole and uses duplex ultrasound 
scanning as a gold standard investigation for comparison 
given its very high correlation with digital subtraction 
angiography in identifying lower limb PAD.9 In doing so, 
this work investigates the accuracy of PAD registers and 




As part of a diagnostic evaluation for a new diagnostic test 
in PAD (NOTEPAD Study), patients registered with PAD 
and control group patients with no registered diagnosis of 
PAD were recruited over a 16-month period between May 
2015 and September 2016 from 15 different GPs across the 
North East of England. The control group patients were 
matched for age and sex.
Duplex ultrasound scanning (DUS) undertaken by 
appropriately trained vascular scientists formed the com-
parative standard for PAD diagnosis for the wider study. 
The vascular scientists were blinded to the registry status of 
the patient being assessed. All patients included had docu-
mented ABPI values reassessed as part of this trial with 
additional multisite photoplethysmography (MPPG) mea-
surements recorded as part of a wider National Institute for 
Health Research (NIHR)–funded (ISRCTN13301188) 
NOTEPAD project investigating novel diagnostic methods 
of assessing PAD. The MPPG evaluation will be analyzed 
and published separately.
Setting
All measurements and patient information were recorded 
within the participating GP, including DUS assessment. 
This was to reduce biasing participants who were unable to 
attend a tertiary centre for assessment and to investigate 
new methods of PAD assessment in primary care.
Participants
Those eligible were identified by the GP and invited to 
attend for initial screening. Patients included were all 
older than 45 years. Baseline demographics and comor-
bidities were recorded by a vascular research nurse spe-
cialist who was blinded to the registry status of the patient. 
At this point, patients were informed of the purpose of 
their participation as part of an informed consent process. 
Control group patients matched for age and sex were then 
identified and invited for participation across the different 
sites. Patients were recruited over a 1-year period. 
Participants were coded using the GP site, followed by the 
number that patient corresponded to in chronological 
order of recruitment from that practice. For example, the 
second patient at GP site 2 was encoded 2-002. No infor-
mation regarding the vascular status of that patient was 
included in the coding structure so as to maintain the 
blinded status of the individual being assessed by the vas-
cular scientist.
Statistical Analysis
The R programming language was used for data cleaning 
and analysis.10 Pearson’s chi-square test with Yates’ conti-
nuity correction was applied to categorical data to assess 
independence and the Welch 2-sample t test was used to 
assess significant difference between the means of the 2 
groups.
Duplex Vascular Ultrasound Scan
All patients underwent bilateral DUS in the primary care 
setting. Each scan was performed by a trained vascular sci-
entist. The vascular scientist was blinded to the registry sta-
tus of the patient and received only the coded participant 
number presenting for assessment. They did not have access 
to the patient’s GP records and produced and submitted 
their reports as soon as the vascular assessment had been 
performed. Patients were assessed while lying supine and 
the limb was scanned from the groin to the ankle. Waveforms 
and velocities were measured to gauge the presence of PAD 
and how severe it was. A summary judgment of the patient’s 
flow status was then made. Degree of vessel disease was 
scored and assessed using a DUS grading scheme. The scan 
protocol is given in the appendix.
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Results
A total of 258 patients were recruited from 15 different GPs 
across the North East of England from May 2015 to 
September 2016. Of these, 8 did not attend as invited for 
DUS imaging, leaving 250 patients (125 registered and 125 
non-PAD registered) for analysis. Table 1 summarizes the 
baseline demographics for both PAD and non-PAD regis-
tered patients.
Of the 125 PAD registered patients recruited, 87 
(69.6%) had DUS evidence of PAD in at least 1 leg when 
scanned. Of the 125 matched controls, 111 (88.8%) had no 
evidence of PAD on DUS imaging. The PAD register false 
positive rate was 30.4% and false negative rate 11.2% 
when assessed by DUS scanning. Across these 2 cohorts 
of patients, the PAD register had a sensitivity and specific-
ity of 86% (95% CI 77%-92%) and 74% (95% CI 67%-
81%), respectively. The positive predictive value, however, 
was 69.6% (95% CI 63%-75%) and negative predictive 
value 88.8% (95% CI 82%-92%). The overall diagnostic 
accuracy of the PAD register was 79.2% (95% CI 
73%-84%).
In the PAD registry cohort, there was a significantly 
higher proportion of patients with ischemic heart disease 
(IHD) (P < .001), stroke (P = .03), transient ischemic 
attack (TIA) (P = .009), and hypertension (P = .017) com-
pared with the control group (Table 1). No significant dif-
ferences were found between the 2 groups with regard to 
age (P = .17), gender (P = .9), body mass index (P = .97), 
diabetes (P = .23), or atrial fibrillation (P = .24). Where 
PAD was confirmed on DUS, 65 (64.4 %) of the 101 
patients positive for PAD had bilateral disease and 36 
(35.6%) had unilateral disease.
Discussion
The results of this case-control study suggest that GPs are 
good at detecting and registering PAD in their patients, with 
the PAD register demonstrating a sensitivity of 86%. There 
is however some room for improvement given the high rate 
of false positives (30.4%). While the false negative rate was 
much lower at 11.2%, this still represents a relatively large 
proportion of the population lacking complete risk factor 
control strategies. Transversely, the suggestion is many 
patients are potentially being exposed to the side effects of 
PAD-protective medication despite lacking true PAD. The 
reasons for misdiagnosing PAD are likely to be multifac-
eted but include the limitations of ABPI and clinical risk 
stratifying tools. Although previous work formally assess-
ing these tools highlights their strengths as diagnostic 
adjuncts for the GP, this study depicts a potentially more 
applicable representation of how well they are used in the 
clinical environment.
Accurate and timely identification of PAD is important 
in prognostication and treatment planning.11 Detecting and 
screening for PAD in primary care has traditionally 
depended on ABPI and cardiovascular risk factor scoring 
systems.6 When used in isolation, these typically have low 
yields in identifying PAD in patients in primary care.6 
Furthermore, a recent Cochrane review identified a lack of 
evidence in the accuracy of ABPI readings in diagnosing 
PAD in people with intermittent claudication.12 ABPI is 
widely lauded as an effective investigation comparable to 
angiographic imaging with a sensitivity of 95% and speci-
ficity of 99%.13 While there is some evidence to suggest 
that ABPI is effective at identifying the presence of PAD in 
asymptomatic at risk individuals in the hospital setting,14 
Table 1. Patient Demographics, Smoking Status, and PAD Registry Status.
Total Register PAD positive Register PAD negative P
Participants, n 250 125 125 —
DUS positive, n (%) 101 (40.4) 87 (69.6) 14 (11.2) <.001
Age, y, mean ± SD 71.8 ± 8.6 72.5 ± 8.5 71.0 ± 8.6 .171
BMI, kg/m2, mean ± SD 27.3 ± 4.6 27.3 ± 5.5 27.3 ± 3.6 .971
Diabetes, n (%) 59 (23.6) 34 (27.2) 25 (20.0) .233
HTN, n (%) 147 (58.8) 83 (66.4) 64 (51.2) .017
Smoking status,a n (%) Never Ex Current Never Ex Current Never Ex Current  
70 (28.0) 128 (51.2) 52 (20.8) 20 (16.0) 66 (52.8) 39 (31.2) 50 (40.0) 62 (49.6) 13 (10.4) <.001
Male:female, n 156:94 79:46 77:48 .896
IHD, n (%) 59 (23.6) 47 (37.6) 12 (9.6) <.001
Stroke, n (%) 18 (7.2) 14 (11.2) 4 (3.2) .026
TIA, n (%) 23 (9.2) 18 (14.4) 5 (4.0) .009
AF, n (%) 20 (8.0) 13 (10.4) 7 (5.6) .244
Abbreviations: PAD, peripheral artery disease; BMI, body mass index; HTN, hypertension; IHD, ischemic heart disease; TIA, transient ischemic attack; 
AF, atrial fibrillation.
a“Current smoking status” was used as the comparator between register PAD positive and register PAD negative.
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ABPI has been demonstrated to be less effective at detect-
ing lower grade stenosis, as may be present in asymptom-
atic patients in the community at risk of developing ischemic 
leg disease.15 Lewis et al16 improved the accuracy of ABPI 
by combining measurements with wave volume analysis, 
producing a 100% sensitive and 76% specific instruments 
when compared with DUS.16
There are a number of reasons that potentially explain 
the limitations of ABPI as a diagnostic tool in primary care.8 
Despite efforts to standardize methodology, there still exists 
a lack of clear consensus in practice about which of the 2 
brachial systolic values are used to calculate ABPI,17 the 
environmental factors such as practitioner room tempera-
ture and referral value thresholds.8,18 Previous investigators 
have explored exercise stress tests pre-ABPI as a means of 
improving diagnostic accuracy.19 However, this is often 
limited by the presence of bilateral disease and the most 
symptomatic limb limiting participation.18 Apart from the 
fact stress testing means more equipment and more time 
taken for an already lengthy investigation in time-pressured 
GP consultations.
ABPI is just one facet in assessing suspected PAD. 
Many practitioners use the presence of intermittent claudi-
cation symptoms. The shared clinical features and typical 
patient demographics of PAD and lumbar spinal stenosis 
mean there is potential for misdiagnosis.20 Studies by Han 
et al20 and Uesugi et al21 demonstrated that PAD is present 
in 4.1% and 6.7% of lumbar spinal stenosis patients, 
respectively, meaning a percentage of patients experience 
diagnostic overshadowing. Although this study would sug-
gest more people are being diagnosed with PAD than have 
disease, it is worth noting that the absence of intermittent 
claudication may still falsely reassure the GP that PAD is 
absent. McDermott et al22 found IC was present in only 
28.5% of patients with established PAD and absence of 
symptoms was more common in male, older, and diabetic 
patients.
PAD and its association to IHD and ischemic stroke is 
well described23,24 owing to a number of common risk fac-
tors.25 This may lead to presumptive diagnoses of PAD 
despite absent clinical or radiographic evidence. Clinical 
scoring systems that help guide diagnosis of related cardio-
vascular disease risk in primary care do not always correlate 
with presence of PAD, despite sharing many risk factors.26
Of all 258 patients invited to follow up, only 8 did not 
attend for DUS imaging. All control group patients were 
age- and sex-matched from the GP registers and were there-
fore likely to be representative of the general population. 
Equal numbers of cases and controls were assessed, appro-
priately matched for age and gender. All measurements, 
including duplex ultrasound scanning were performed 
within the practice to represent better the population under 
the care of the community physician. Although previous 
work has assessed different tools available to the practitioner 
in terms of sensitivity and specificity, this study evaluates 
how well current practice in primary care is establishing the 
burden of PAD in their practices.
Limitations
GP registers were taken from practices listed under a 
research registry collaborative and selected based on will-
ingness to cooperate with the study in order to allow for 
sufficient recruitment of patient numbers. All practices 
were within one region of the United Kingdom and may not 
be representative of national and international populations. 
Practices may have varied in their means of forming a diag-
nosis, for example, all practices studied had the capacity to 
measure ABPI, though how many PAD registered patients 
diagnosis was based on an ABPI value is not known.
Implications for Research and Practice
In light of these limitations, new objective assessment 
tools for PAD in primary care have been evaluated. The 
use of photoplethysmography in determining pulsatile 
changes in the microcirculation of the skin at the toes is 
long standing.27 More sophisticated applications of this 
vascular optics technology can be used to identify changes 
in waveforms between healthy and arterially diseased 
legs.28 Further work performed as part of this study aims 
to assess its potential for the GP in providing a more sensi-
tive and specific tool in assessing PAD, and without add-
ing to an already time pressured consultation.
Appendix
DUS Protocol Used in Assessment of Patients
Scan Protocol
•• Bilateral scan of lower limb arteries to be performed 
on each subject
•• Analysis by segments with final summary
•• For each segment tick one box in each lettered group
•• Comment on any factors affecting diagnosis
•• Give your overall opinion on whether PAD is present 
and to what degree
Definition: A diagnosis of PAD will be made if there is any of
(a) At least one stenosis of >50%
(b) An occlusion
(c) General narrowing of such a degree that the flow is 
impeded and the waveform is damped in popliteal 
or distal segment.
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